Skip to content

Do currently recommended Bayley-III cutoffs overestimate motor impairment in infants born <27 weeks gestation?

CPQCC Publication
TitleDo currently recommended Bayley-III cutoffs overestimate motor impairment in infants born <27 weeks gestation?
Publication TypeJournal Article
Year of Publication2015
AuthorsDuncan AF, Bann C, Boatman C, Hintz SR, Vaucher YE, Vohr BR, Yolton K, Heyne RJ
Corporate AuthorsEunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
JournalJ Perinatol
Volume35
Issue7
Pagination516-21
Date Published2015 Jul
ISSN1476-5543
KeywordsChild Development, Female, Gestational Age, Humans, Infant, Extremely Premature, Infant, Newborn, Male, Motor Skills Disorders, Neuropsychological Tests, Predictive Value of Tests, Retrospective Studies, Sensitivity and Specificity
Abstract

OBJECTIVE: To determine whether a Bayley-III motor composite score of 85 may overestimate moderate-severe motor impairment by analyzing Bayley-III motor components and developing cut-point scores for each.

STUDY DESIGN: Retrospective study of 1183 children born <27 weeks gestation at NICHD Neonatal Research Network centers and evaluated at 18-22 months corrected age. Gross Motor Function Classification System determined gross motor impairment. Statistical analyses included linear and logistic regression and sensitivity/specificity.

RESULTS: Bayley-III motor composite scores were strong indicators of gross/fine motor impairment. A motor composite cut-point of 73 markedly improved the specificity for identifying gross and/or fine motor impairment (94% compared with a specificity of 76% for the proposed new cut-point of 85). A Fine Motor Scaled Score <3 differentiated mild from moderate-severe fine motor impairment.

CONCLUSIONS: This study indicates that a Bayley-III motor composite score of 85 may overestimate impairment. Further studies are needed employing term controls and longer follow-up.

DOI10.1038/jp.2014.243
Alternate JournalJ Perinatol
PubMed ID25634519
PubMed Central IDPMC4531094
Grant ListU10 HD021385 / HD / NICHD NIH HHS / United States
U10 HD053124 / HD / NICHD NIH HHS / United States
U10 HD053119 / HD / NICHD NIH HHS / United States
U10 HD021364 / HD / NICHD NIH HHS / United States
UG1 HD087229 / HD / NICHD NIH HHS / United States
UG1 HD053089 / HD / NICHD NIH HHS / United States
U10 HD040461 / HD / NICHD NIH HHS / United States
UG1 HD034216 / HD / NICHD NIH HHS / United States
U10 HD027871 / HD / NICHD NIH HHS / United States
U10 HD027851 / HD / NICHD NIH HHS / United States
UG1 HD021364 / HD / NICHD NIH HHS / United States
UG1 HD027880 / HD / NICHD NIH HHS / United States
UG1 HD053109 / HD / NICHD NIH HHS / United States
UG1 HD068278 / HD / NICHD NIH HHS / United States
U10 HD053089 / HD / NICHD NIH HHS / United States
U10 HD027856 / HD / NICHD NIH HHS / United States
U10 HD021373 / HD / NICHD NIH HHS / United States
U10 HD027880 / HD / NICHD NIH HHS / United States
U10 HD053109 / HD / NICHD NIH HHS / United States
U10 HD040689 / HD / NICHD NIH HHS / United States
U10 HD040492 / HD / NICHD NIH HHS / United States
U10 HD027853 / HD / NICHD NIH HHS / United States
U10 HD027904 / HD / NICHD NIH HHS / United States
U10 HD034216 / HD / NICHD NIH HHS / United States
U10 HD036790 / HD / NICHD NIH HHS / United States